Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Number of tumor foci predicts prognosis in papillary thyroid cancer

Authors: Ning Qu, Ling Zhang, Qing-hai Ji, Yong-xue Zhu, Zhuo-ying Wang, Qiang Shen, Yu Wang, Duan-shu Li

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Papillary thyroid cancer (PTC) often presents as multifocal. However, the association of multifocality with poor prognosis remains controversial. The aim of this retrospective study was to identify the characteristics of PTC with multiple foci and to evaluate the association between multifocality and prognosis.

Methods

We reviewed the medical records of 496 patients who underwent total thyroidectomy for PTC. Patients were classified as G1 (1 tumor focus), G2 (2 foci), and G3 (3 or more foci). We analyzed the clinicopathological features and clinical outcomes in each classification. A Cox regression model was used to assess the relationship between multifocality and recurrence or cancer mortality.

Results

The G1, G2 and G3 groups included 287, 141 and 68 patients, respectively. The mean age was 47.1 ± 16.1 yr in G1, 41.1 ± 18.4 yr in G2, and 35.5 ± 15.9 yr in G3 and differed significantly among the 3 groups (p = 0.001). The proportion of extrathyroidal extension, central lymph node metastasis (CLNM), and lateral lymph node metastasis (LLNM) in the G1 to G3 groups increased with increasing number of tumor foci. The Kaplan–Meier curves revealed that G3 had the shortest recurrence-free survival, and differences were significant among the 3 groups (p = 0.001, Log Rank test). Furthermore, cancer-specific survival rates decreased significantly with increasing number of tumor foci (p = 0.041). Independent predictors of recurrence by multivariate Cox analysis included >3 tumor foci [HR 2.60, 95% confidence interval (CI) 1.53-4.39, p = 0.001] and extrathyroidal extension (HR 1.95, CI 1.12-3.38, p = 0.018).

Conclusion

An increase in the number of tumors is associated with a tendency toward more aggressive features and predicts poor prognosis in PTC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 2014, 64 (1): 9-29. 10.3322/caac.21208.CrossRefPubMed Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 2014, 64 (1): 9-29. 10.3322/caac.21208.CrossRefPubMed
2.
go back to reference Hung W, Sarlis NJ: Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002, 12 (8): 683-702. 10.1089/105072502760258668.CrossRefPubMed Hung W, Sarlis NJ: Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002, 12 (8): 683-702. 10.1089/105072502760258668.CrossRefPubMed
3.
go back to reference Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A: Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer. 1992, 70 (6): 1585-1590. 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z.CrossRefPubMed Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A: Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer. 1992, 70 (6): 1585-1590. 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z.CrossRefPubMed
4.
go back to reference Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Bhattacharya A, Lea R, Grebe SK: Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology. 2010, 42 (6): 524-533. 10.3109/00313025.2010.508780.CrossRefPubMed Jovanovic L, Delahunt B, McIver B, Eberhardt NL, Bhattacharya A, Lea R, Grebe SK: Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology. 2010, 42 (6): 524-533. 10.3109/00313025.2010.508780.CrossRefPubMed
5.
go back to reference Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ: Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010, 20 (2): 147-152. 10.1089/thy.2008.0243.CrossRefPubMed Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ: Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010, 20 (2): 147-152. 10.1089/thy.2008.0243.CrossRefPubMed
6.
go back to reference Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M: Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005, 90 (10): 5723-5729. 10.1210/jc.2005-0285.CrossRefPubMed Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M: Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005, 90 (10): 5723-5729. 10.1210/jc.2005-0285.CrossRefPubMed
7.
go back to reference Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994, 97 (5): 418-428. 10.1016/0002-9343(94)90321-2.CrossRefPubMed Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994, 97 (5): 418-428. 10.1016/0002-9343(94)90321-2.CrossRefPubMed
8.
go back to reference Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH: Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003, 98 (1): 31-40. 10.1002/cncr.11442.CrossRefPubMed Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH: Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003, 98 (1): 31-40. 10.1002/cncr.11442.CrossRefPubMed
9.
go back to reference Zhang L, Wei WJ, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y: Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012, 97 (4): 1250-1257. 10.1210/jc.2011-1546.CrossRefPubMed Zhang L, Wei WJ, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y: Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012, 97 (4): 1250-1257. 10.1210/jc.2011-1546.CrossRefPubMed
10.
go back to reference Dinse GE, Lagakos SW: Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics. 1982, 38 (4): 921-932. 10.2307/2529872.CrossRefPubMed Dinse GE, Lagakos SW: Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics. 1982, 38 (4): 921-932. 10.2307/2529872.CrossRefPubMed
11.
go back to reference Gill RD: Multistate life-tables and regression models. Math Popul Stud. 1992, 3 (4): 259-276. 10.1080/08898489209525345.CrossRefPubMed Gill RD: Multistate life-tables and regression models. Math Popul Stud. 1992, 3 (4): 259-276. 10.1080/08898489209525345.CrossRefPubMed
12.
go back to reference Kim HJ, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH: Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Head Neck. 2014, doi:10.1002/hed.23650 Kim HJ, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH: Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Head Neck. 2014, doi:10.1002/hed.23650
13.
go back to reference Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X, Huang T: Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013, 20 (3): 746-752. 10.1245/s10434-012-2654-2.CrossRefPubMed Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X, Huang T: Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013, 20 (3): 746-752. 10.1245/s10434-012-2654-2.CrossRefPubMed
14.
go back to reference Zhou YL, Gao EL, Zhang W, Yang H, Guo GL, Zhang XH, Wang OC: Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol. 2012, 10: 67-10.1186/1477-7819-10-67.CrossRefPubMedPubMedCentral Zhou YL, Gao EL, Zhang W, Yang H, Guo GL, Zhang XH, Wang OC: Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol. 2012, 10: 67-10.1186/1477-7819-10-67.CrossRefPubMedPubMedCentral
15.
go back to reference Shepet K, Alhefdhi A, Lai N, Mazeh H, Sippel R, Chen H: Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival. Ann Surg Oncol. 2013, 20 (5): 1451-1455. 10.1245/s10434-012-2757-9.CrossRefPubMed Shepet K, Alhefdhi A, Lai N, Mazeh H, Sippel R, Chen H: Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival. Ann Surg Oncol. 2013, 20 (5): 1451-1455. 10.1245/s10434-012-2757-9.CrossRefPubMed
16.
go back to reference Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH: Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg. 2013, 37 (2): 376-384. 10.1007/s00268-012-1835-2.CrossRefPubMed Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH: Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg. 2013, 37 (2): 376-384. 10.1007/s00268-012-1835-2.CrossRefPubMed
17.
go back to reference Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010, 17 (6): 1471-1474. 10.1245/s10434-010-0985-4.CrossRefPubMed Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010, 17 (6): 1471-1474. 10.1245/s10434-010-0985-4.CrossRefPubMed
18.
go back to reference Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A: Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006, 30 (1): 91-99. 10.1007/s00268-005-0113-y.CrossRefPubMed Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A: Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006, 30 (1): 91-99. 10.1007/s00268-005-0113-y.CrossRefPubMed
19.
go back to reference Wada N, Nakayama H, Suganuma N, Masudo Y, Rino Y, Masuda M, Imada T: Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J Clin Endocrinol Metab. 2007, 92 (1): 215-218. 10.1210/jc.2006-1443.CrossRefPubMed Wada N, Nakayama H, Suganuma N, Masudo Y, Rino Y, Masuda M, Imada T: Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J Clin Endocrinol Metab. 2007, 92 (1): 215-218. 10.1210/jc.2006-1443.CrossRefPubMed
20.
go back to reference Riss JC, Peyrottes I, Chamorey E, Haudebourg J, Sudaka A, Benisvy D, Marcy PY, Nao EE, Demard F, Vallicioni J, Poissonnet G, Dassonville O, Santini J, Bozec A: Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2012, 129 (4): 175-178. 10.1016/j.anorl.2011.11.003.CrossRefPubMed Riss JC, Peyrottes I, Chamorey E, Haudebourg J, Sudaka A, Benisvy D, Marcy PY, Nao EE, Demard F, Vallicioni J, Poissonnet G, Dassonville O, Santini J, Bozec A: Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2012, 129 (4): 175-178. 10.1016/j.anorl.2011.11.003.CrossRefPubMed
21.
go back to reference Ogilvie JB, Patel KN, Heller KS: Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas. Surgery. 2010, 148 (6): 1222-1226. 10.1016/j.surg.2010.09.007. discussion 1226–1227CrossRefPubMed Ogilvie JB, Patel KN, Heller KS: Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas. Surgery. 2010, 148 (6): 1222-1226. 10.1016/j.surg.2010.09.007. discussion 1226–1227CrossRefPubMed
22.
go back to reference Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V: Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009, 19 (7): 707-716. 10.1089/thy.2008.0270.CrossRefPubMed Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V: Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009, 19 (7): 707-716. 10.1089/thy.2008.0270.CrossRefPubMed
23.
go back to reference Connor MP, Wells D, Schmalbach CE: Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy. Otolaryngol Head Neck Surg. 2011, 144 (2): 210-215. 10.1177/0194599810391616.CrossRefPubMed Connor MP, Wells D, Schmalbach CE: Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy. Otolaryngol Head Neck Surg. 2011, 144 (2): 210-215. 10.1177/0194599810391616.CrossRefPubMed
24.
go back to reference Moo TA, Umunna B, Kato M, Butriago D, Kundel A, Lee JA, Zarnegar R, Fahey TJ: Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg. 2009, 250 (3): 403-408.PubMed Moo TA, Umunna B, Kato M, Butriago D, Kundel A, Lee JA, Zarnegar R, Fahey TJ: Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg. 2009, 250 (3): 403-408.PubMed
25.
go back to reference Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC: Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg. 2009, 249 (5): 840-844. 10.1097/SLA.0b013e3181a40919.CrossRefPubMed Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC: Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg. 2009, 249 (5): 840-844. 10.1097/SLA.0b013e3181a40919.CrossRefPubMed
Metadata
Title
Number of tumor foci predicts prognosis in papillary thyroid cancer
Authors
Ning Qu
Ling Zhang
Qing-hai Ji
Yong-xue Zhu
Zhuo-ying Wang
Qiang Shen
Yu Wang
Duan-shu Li
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-914

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine